Poststroke recovery in patients with type 2 diabetes mellitus


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Type 2 diabetes mellitus (DM2) can actively influence course of ischemic cerebral circulation disorders (CCDs), being the most important risk factor for their development. Objective. Evaluation of the effect of DM2 on the severity of neurological disorders and the outcome of ischemic CCDs in DM2 patients with, taking into account the severity and duration of history of carbohydrate metabolism disorders. Material and methods. A prospective study included 156 patients with ischemic stroke (IS) followed-up in the Scientific Center of Neurology. The patients were divided into two groups: group 1 (n=87) consisted of DM2 patients, group 2 (n=59) - patients without diabetes. All patients were assessed according to the following scales: National Institutes of Health (NIHSS) stroke scale, the Scandinavian stroke scale on the 1st and 14th days of acute cerebral circulation disorder, the modified Rankin scale (mRS), the Barthel Index (BI) for activities in daily living on the 14th day; DM2 patients underwent an assessment of carbohydrate metabolism. Results. The best results of treatment were achieved in patients without diabetes: NIHSS score and the Scandinavian stroke scale score were 5.4±4.7 against 7.6±5.1 points and 48.5±17.8 against 46±13.6 points, respectively. According mRS and the Barthel inDex, the average scores in patients with and without DM2 were 2.6±1.6 against 2.1±1.9 and 70.6±27.1 against 84.2±19.7, respectively. CCDs in DM2 patients developed on the background of elevated glycated hemoglobin (HbA1c) levels on average up to 8.4%, and the recovery of neurological deficit and the stroke outcome depended on the of HbA1c level and the duration of DM2 history. Conclusion. The presence of DM2, its duration and the unsatisfactory glycemic control contribute to the deterioration of the prognosis for recovery of neurological deficit and the stroke outcome.

Full Text

Restricted Access

About the authors

M. M Tanashyan

Scientific Center of Neurology

SPIN-code: 7191-1163

M. Yu Maksimova

Scientific Center of Neurology

Ksenia V. Antonova

Scientific Center of Neurology

Email: kseniya.antonova@mail.ru
SPIN-code: 7737-4712
PhD

A. A Raskurazhev

Scientific Center of Neurology

N. V Shakhparonova

Scientific Center of Neurology

T. I Romantsova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

SPIN-code: 3855-5410

References

  1. Суслина З.А., Пирадов М.А., Домашенко М.А. Инсульт: оценка проблемы (15 лет спустя). Журнал неврологии и психиатрии им. С.С. Корсакова. 2014;11:5-13
  2. Mozaffarian D., Benjamin E.J., Go A.S., et al. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation. 2015;131(4):29-322. Doi: 10.1161/ CIR.0000000000000152
  3. Walker M.F., Sunnerhagen K.S., Fisher R.J. Evidence-Based Community. Stroke Rehabilitation. Stroke. 2013;44:293-97. doi: 10.1161/STROKEAHA.111.639914.
  4. Luitse M.J., Biessels G.J., Rutten G.E., Kappelle L.J. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet. Neurol. 2012;11:261-71. Doi: 10.1016/ S1474-4422(12)70005-4.
  5. Дедов И.И., Шестакова М.В., Викулова О.К. и др. Сахарный диабет в Российской Федерации: распространенность, заболеваемость, смертность, параметры углеводного обмена и структура сахароснижающей терапии по данным Федерального регистра сахарного диабета, статус 2017 г. Сахарный диабет. 2018;21(3):144-59. doi: 10.14341/DM9686.
  6. Akhtar N., Kamran S., Singh R., et al. The Impact of Diabetes on Outcomes After Acute Ischemic Stroke: A Prospective Observational Study. J. Stroke Cerebrovasc Dis. 2019;28(3):619-26. doi: 10.1016/j.jstrokecere brovasdis.2018.11.003.
  7. Liu L., Zhan L., Wang Y., et al. Metabolic syndrome and the short-term prognosis of acute ischemic stroke: a hospital-based retrospective study. Lipids in Health and Disease. 2015;14:76. doi: 10.1186/s12944-015-0080-8.
  8. Wang H., Cheng Y., Chen S., et al. Impact of Elevated Hemoglobin A1c Levels on Functional Outcome in Patients with Acute Ischemic Stroke. J. Stroke Cerebrovasc Dis. 2019;28(2):470-76. doi: 10.1016/j.jstrokecereb rovasdis.2018.10.026.
  9. Multicenter trial of hemodilution in ischemic stroke-background and study protocol. Scand. Stroke Study Group. Stroke. 1985;16:885-90.
  10. Goldstein L.B., Bertels C., Davis J.N. Interrater reliability of the NIH stroke scale. Arch Neurol. 1989; 46:660-62.
  11. Duncan P.W., Jorgensen H.S., Wade D.T. Outcome Measures in Acute Stroke Trials: A Systematic Review and Some Recommendations to Improve Practice. Stroke. 2000;31:1429-38.
  12. van Swieten J.C., Koudstaal P.J., Visser M.C., et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988; 19:604-7.
  13. Дедов И.И., Шестакова М.В., Майоров А.Ю. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 8-й выпуск. Сахарный диабет.2017;20(Suppl. 1):1-121. doi: 10.14341/DM20171S8.
  14. Костырева М.В., Шабалина А.А., Лютова Л.В. и др. Сравнительное изучение состояния систем гемостаза, фибринолиза и липидного спектра у больных острыми нарушениями мозгового кровообращения и дисциркуляторной энцефалопатией. Тромбоз, гемостаз и реология. 2010;2(42):61-8.
  15. Nannetti L., Paci M., Baccini M., et al. Recovery from stroke in patients with diabetes mellitus. J. Diab Comps. 2009;23:249-54. Doi: 10.1016/j. jdiacomp.2008.02.008.
  16. Zheng Z., Wu J., Wang R., Zeng Y. Diabetes mellitus may induce cardiovascular disease by decreasing neuroplasticity. Funct Neurol. 2014;29(1):7-13.
  17. Ануфриев П.Л., Танашян М.М., Гулевская Т.С. и др. Особенности атеросклероза церебральных артерий и патоморфологии инфарктов головного мозга при сахарном диабете 2 типа. Анналы клинической и экспериментальной неврологии. 2015;9(3):4-9.
  18. Танашян М.М., Лагода О.В., Гулевская Т.С. и др. Прогрессирующий церебральный атеросклероз: клинические, биохимические и морфологические аспекты. Анналы клинической и экспериментальной неврологии. 2013;7(4):4-9.
  19. Антонова К.В., Медведев Р.Б., Шабалина А.А. и др. Нарушения углеводного обмена и церебральный атеросклероз у больных с ишемическими нарушениями мозгового кровообращения. Анналы клинической и экспериментальной неврологии. 2016;10(1):20-6.
  20. Балаболкин М.И., Петунина Н.А., Тельнова М.Э. и др. Роль инсулиновой терапии в компенсации сахарного диабета РМЖ. 2007;15(27):2072 -78.
  21. Suh S.W., Shin B.S., Ma H., Van Hoecke M., et al. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann Neurol. 2008;64:654-63. doi: 10.1002/ana.21511.
  22. Desilles J.P., Syvannarath V., Ollivier V., et al. Exacerbation of thromboinflammation by hyperglycemia precipitates cerebral infarct growth and hemorrhagic transformation. Stroke. 2017;48:1932-40. doi: 10.1161/STROKEAHA.117.017080.
  23. Choi K.H., Kim J.H., Kang K.W., et al. HbA1c (Glycated Hemoglobin) Levels and Clinical Outcome PostMechanical Thrombectomy in Patients With Large Vessel Occlusion. Stroke. 2018;50:119-26. doi: 10.1161/STROKEAHA.118.021598.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies